Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
Abstract Tissue factor (TF) is a protein that plays a critical role in blood clotting, but recent research has also shown its involvement in cancer development and progression. Herein, we provide an overview of the structure of TF and its involvement in signaling pathways that promote cancer cell pr...
Wedi'i Gadw mewn:
Prif Awduron: | Seyed Esmaeil Ahmadi (Awdur), Ashkan Shabannezhad (Awdur), Amir Kahrizi (Awdur), Armin Akbar (Awdur), Seyed Mehrab Safdari (Awdur), Taraneh Hoseinnezhad (Awdur), Mohammad Zahedi (Awdur), Soroush Sadeghi (Awdur), Mahsa Golizadeh Mojarrad (Awdur), Majid Safa (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
BMC,
2023-06-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy
gan: Seyed Esmaeil Ahmadi, et al.
Cyhoeddwyd: (2024) -
Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?
gan: Mayte Sola, et al.
Cyhoeddwyd: (2020) -
PROteolysis Targeting Chimeras: A new cutting‐edge nanomedicine for colorectal cancer
gan: Swastika Maitra, et al.
Cyhoeddwyd: (2024) -
Factor XI and coagulation. Factor XI inhibitors - antithrombotic perspectives
gan: Vlădăreanu Ana-Maria, et al.
Cyhoeddwyd: (2024) -
Hematuria in Patients with Congenital Coagulation Factor Deficiencies
gan: Nihal Karadaş, et al.
Cyhoeddwyd: (2022)